Plasma PCSK9 Levels and Clinical Outcomes in the TNT (Treating to New Targets) Trial: A Nested Case-Control Study

Study Questions:

Do proprotein convertase subtilisin kexin type 9 (PCSK9) levels predict cardiovascular (CV) risk in patients on statin therapy?